LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immune Function Predicts Infection for Pediatric Trauma Patients

By LabMedica International staff writers
Posted on 23 Jul 2014
Image: Schematic representation of signaling pathways involved in lipopolysaccharide (LPS) induced tumor necrosis factor-alpha (TNFα) production in human cells (Photo courtesy of Dr. Laurence Hoareau).
Image: Schematic representation of signaling pathways involved in lipopolysaccharide (LPS) induced tumor necrosis factor-alpha (TNFα) production in human cells (Photo courtesy of Dr. Laurence Hoareau).
An immune marker that predicts which patients are likely to develop a hospital-acquired infection has been identified in critically ill children with traumatic injuries.

The clinical implementation of quick-turnaround immune function tests and treatments to prevent or reverse immune system damage following critical illness or injury in pediatric patients is essential. This especially true where hospital-acquired, or nosocomial, infections pose a threat to any patient, but people who have suffered a traumatic injury are at the highest risk.

Clinical scientists at the Nationwide Children's Hospital (Columbus, OH, USA) collected blood samples from 21 healthy children and 76 critically injured children, 18 years of age or younger. In a test tube, they exposed each sample to lipopolysaccharide (LPS), a known stimulant of the immune response. When healthy cells are exposed to LPS, it prompts the production of tumor necrosis factor-alpha (TNFα), a type of protein called a cytokine that is part of the first line of defense in the body's innate immune system.

Sixteen critically injured subjects developed nosocomial infection. Those subjects had higher plasma interleukin (IL)-6 and IL-10 levels on post-trauma day (PTD) 1-2 compared to those who recovered without infection and outpatient controls. Ex vivo LPS-induced TNFα production capacity was lower in children on PTD 1-2 and over the first week following injury in those who went on to develop infection. The team found that patients who received a transfusion of blood that had been stored for more than two weeks prior to transfusion had a lower level of TNFα production than children whose transfused blood was less than two weeks old, regardless of the severity of their original injury.
The authors concluded that trauma-induced innate immune suppression is common in critically injured children and is associated with increased risks for the development of nosocomial infection. Potential exacerbating factors, including red blood cell transfusion and potential therapies for pediatric trauma-induced innate immune suppression are deserving of further study.

Mark W. Hall, MD, the senior author of the study said, “With a normal immune response, the body responds to pathogens and eliminates them before they cause an infection. But in many forms of critical illness, we see the immune system unable to do those things. Studies in adults with traumatic injuries have found that immune function is decreased in those patients, but this is the first data to show that the same thing happens in critically injured children.” The study was published on June 21, 2014, in the journal Shock.

Related Links:
Nationwide Children's Hospital



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more